The FDA granted orphan drug designation to CTD402 for relapsed or refractory T-cell acute lymphoblastic leukemia and ...
Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...
Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...
Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...
Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make immune-based treatments far more powerful. They found that tumors use a ...
UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results